Search

The integration of artificial intelligence (AI) into healthcare systems marked a pivotal evolution in clinical analytics architectures and governance structures, transforming data-driven decision-making from siloed, retrospective analyses to dynamic, predictive, and integrated frameworks. This period witnessed rapid advancements in machine learning (ML) applications for healthcare infrastructure, encompassing electronic health records (EHRs), imaging diagnostics, population health management, and real-time monitoring systems. Key developments included the shift toward federated learning to address data privacy concerns, the emergence of explainable AI (XAI) to enhance clinical trustworthiness, and the standardization of regulatory pathways for AI as medical devices. Architecturally, healthcare systems evolved from static analytics pipelines—where data ingestion, model training, and inference occurred in isolated phases—to adaptive, closed-loop configurations that incorporate feedback mechanisms for continuous model refinement and human-AI collaboration. Governance structures are adapted accordingly, emphasizing ethical frameworks to mitigate bias, ensure data equity, and promote algorithmic accountability, particularly for underserved populations. This review synthesizes literature from this timeframe, highlighting how AI-enabled analytics architectures facilitated precision medicine by integrating multimodal data sources, such as genomics, wearables, and social determinants of health, into cohesive systems. Challenges in interoperability and scalability were addressed through consensus guidelines like CONSORT-AI and SPIRIT-AI, which promoted transparent reporting of AI interventions in clinical trials. Moreover, the COVID-19 pandemic accelerated AI deployment in pandemic response systems, underscoring the need for resilient architectures capable of handling real-time data surges and uncertainty communication. Governance evolved to include multi-stakeholder perspectives, from regulatory bodies such as the FDA to clinical practitioners, ensuring that AI tools align with evidence-based medicine. This narrative review provides an original systems-level framing, organizing the literature around data-to-decision cycles, infrastructural integration, and governance maturation. By examining cross-study insights, it reveals how AI has fostered intelligent healthcare ecosystems, reducing diagnostic bias across diverse cohorts and enhancing decision support without over-relying on black-box models. Ultimately, this synthesis underscores the transition from AI as a supplementary tool to a foundational element of healthcare systems, paving the way for equitable, efficient clinical analytics.

Sepsis remains a major cause of mortality in intensive care units worldwide, with an estimated 49 million cases and over 11 million deaths annually, highlighting the need for earlier detection to improve outcomes. This systematic review synthesizes evidence on machine learning models for early sepsis prediction in adult ICU patients from 2017 to 2021, focusing on prediction horizons, data modalities, and validation approaches. A comprehensive search of PubMed, Embase, IEEE Xplore, ACM Digital Library, and arXiv identified studies meeting criteria for ICU-based sepsis prediction with at least a 4-hour forecast window, following PRISMA guidelines. Of 1,478 records screened, 35 studies were included, with prediction horizons ranging from 4 to 24 hours and most relying on hourly vital sign data and internal validation. Reported performance varied widely depending on horizon length, data sampling, and validation rigor, with external validation generally producing lower but more realistic results. Overall, while machine learning models show promising predictive ability, limitations in generalizability and standardization remain, emphasizing the need for stronger validation frameworks and reporting practices to support clinical translation.

Hospital discharge delays are costly, disrupt inpatient capacity, and expose patients to avoidable iatrogenic harm. Early identification of patients likely to be ready for discharge could improve patient flow and reduce operational bottlenecks. Current discharge decisions often rely on subjective judgment, fragmented documentation, and sequential review by multiple clinical teams. No single tool routinely integrates the morning snapshot of clinical readiness. This article proposes a predictive model that estimates the probability of same-day discharge readiness by 9 am. The model uses morning laboratory results, active medication orders, vital sign stability, mobility documentation, and pending consultation status. The proposed approach is a supervised classification model using gradient-boosted trees trained on historical inpatient encounters. Features would be assembled from electronic health record data available before morning rounds. Conceptually, the model would generate a calibrated discharge readiness list for clinical review. This list could help care teams focus on borderline patients and support bed-management forecasting. The model could accelerate discharge throughput while maintaining safety by surfacing hidden readiness signals. It is intended to complement, not replace, clinical judgment.

Missed medication doses in long-term care facilities compromise resident safety and arise from intersecting medication, resident, staffing, route, and workload factors. These risks are especially important where residents have complex regimens and high care dependency. Current medication safety approaches in long-term care are often retrospective, audit-based, or broadly applied across all residents. They do not forecast which specific resident–medication pass combinations are most vulnerable before administration occurs. The objective is to describe a predictive model that could estimate the probability of a missed medication dose for each resident–medication pass combination. The model would use medication complexity, resident dependency, staff availability, administration route, and shift-level workload indicators. A supervised classification approach could be trained using electronic medication administration records, staffing rosters, resident assessment data, and medication order characteristics. The model would output a dose-level missed-dose risk score before the relevant medication pass. Conceptually, the model would identify high-risk medication–resident–shift triples and provide an interpretable explanation of dominant risk contributors. For example, the system could flag a non-oral high-risk medication scheduled during a low-staffed morning medication round. Such a model could support proactive prevention by directing nursing attention toward the most vulnerable doses before they are missed. It could also inform shift-level workload planning and safer medication pass organization.